114 related articles for article (PubMed ID: 30267148)
1. [FGFR3 overexpression is a relevant alteration in colorectal cancer].
Fromme JE; Schildhaus HU
Pathologe; 2018 Dec; 39(Suppl 2):189-192. PubMed ID: 30267148
[TBL] [Abstract][Full Text] [Related]
2. FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis.
Fromme JE; Schmitz K; Wachter A; Grzelinski M; Zielinski D; Koppel C; Conradi LC; Homayounfar K; Hugo T; Hugo S; Lukat L; Rüschoff J; Ströbel P; Ghadimi M; Beißbarth T; Reuter-Jessen K; Bleckmann A; Schildhaus HU
Oncotarget; 2018 Aug; 9(63):32204-32218. PubMed ID: 30181810
[TBL] [Abstract][Full Text] [Related]
3. Complexity of FGFR signalling in metastatic urothelial cancer.
Rodriguez-Vida A; Saggese M; Hughes S; Rudman S; Chowdhury S; Smith NR; Lawrence P; Rooney C; Dougherty B; Landers D; Kilgour E; Arkenau HT
J Hematol Oncol; 2015 Oct; 8():119. PubMed ID: 26497743
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor receptor (FGFR) gene amplifications are rare events in bladder cancer.
Fischbach A; Rogler A; Erber R; Stoehr R; Poulsom R; Heidenreich A; Schneevoigt BS; Hauke S; Hartmann A; Knuechel R; Veeck J; Gaisa NT
Histopathology; 2015 Apr; 66(5):639-49. PubMed ID: 24898159
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of FGFR Alterations and FGFR mRNA Expression in Metastatic Urothelial Cancer Undergoing Checkpoint Inhibitor Therapy.
Tully KH; Jütte H; Wirtz RM; Jarczyk J; Santiago-Walker A; Zengerling F; Breyer J; Sikic D; Kriegmair MC; von Hardenberg J; Wullich B; Taubert H; Weyerer V; Stoehr R; Bolenz C; Burger M; Porubsky S; Hartmann A; Roghmann F; Erben P; Eckstein M
Urology; 2021 Nov; 157():93-101. PubMed ID: 34153367
[TBL] [Abstract][Full Text] [Related]
6. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
Cornish EE; Natoli RC; Hendrickson A; Provis JM
Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
[TBL] [Abstract][Full Text] [Related]
7. Targeting the Src Pathway Enhances the Efficacy of Selective FGFR Inhibitors in Urothelial Cancers with FGFR3 Alterations.
Lima NC; Atkinson E; Bunney TD; Katan M; Huang PH
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32370101
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer.
Sato T; Oshima T; Yoshihara K; Yamamoto N; Yamada R; Nagano Y; Fujii S; Kunisaki C; Shiozawa M; Akaike M; Rino Y; Tanaka K; Masuda M; Imada T
Oncol Rep; 2009 Jan; 21(1):211-6. PubMed ID: 19082464
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of FGFR3 actions in endocrine resistant breast cancer.
Tomlinson DC; Knowles MA; Speirs V
Int J Cancer; 2012 Jun; 130(12):2857-66. PubMed ID: 21792889
[TBL] [Abstract][Full Text] [Related]
10. Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries.
Hughes SE
Cardiovasc Res; 1996 Sep; 32(3):557-69. PubMed ID: 8881516
[TBL] [Abstract][Full Text] [Related]
11. FGFR3 expression in primary invasive bladder cancers and matched lymph node metastases.
Turo R; Harnden P; Thygesen H; Fleischmann A; Thalmann GN; Seiler R; Cross WR; Knowles MA
J Urol; 2015 Jan; 193(1):325-30. PubMed ID: 24933362
[TBL] [Abstract][Full Text] [Related]
12. FGFR signalling in women's cancers.
Fearon AE; Gould CR; Grose RP
Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
[TBL] [Abstract][Full Text] [Related]
13. Ligand-associated ERBB2/3 activation confers acquired resistance to FGFR inhibition in FGFR3-dependent cancer cells.
Wang J; Mikse O; Liao RG; Li Y; Tan L; Janne PA; Gray NS; Wong KK; Hammerman PS
Oncogene; 2015 Apr; 34(17):2167-77. PubMed ID: 24909170
[TBL] [Abstract][Full Text] [Related]
14. Fibroblast growth factor receptor 1 and 3 expression is associated with regulatory PI3K/AKT kinase activity, as well as invasion and prognosis, in human laryngeal cancer.
Starska K; Forma E; Lewy-Trenda I; Stasikowska-Kanicka O; Skóra M; Bryś M
Cell Oncol (Dordr); 2018 Jun; 41(3):253-268. PubMed ID: 29299828
[TBL] [Abstract][Full Text] [Related]
15. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
Helsten T; Schwaederle M; Kurzrock R
Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
[TBL] [Abstract][Full Text] [Related]
17. Targeting protein arginine methyltransferase 5 inhibits colorectal cancer growth by decreasing arginine methylation of eIF4E and FGFR3.
Zhang B; Dong S; Zhu R; Hu C; Hou J; Li Y; Zhao Q; Shao X; Bu Q; Li H; Wu Y; Cen X; Zhao Y
Oncotarget; 2015 Sep; 6(26):22799-811. PubMed ID: 26078354
[TBL] [Abstract][Full Text] [Related]
18. Prox1 promotes lineage-specific expression of fibroblast growth factor (FGF) receptor-3 in lymphatic endothelium: a role for FGF signaling in lymphangiogenesis.
Shin JW; Min M; Larrieu-Lahargue F; Canron X; Kunstfeld R; Nguyen L; Henderson JE; Bikfalvi A; Detmar M; Hong YK
Mol Biol Cell; 2006 Feb; 17(2):576-84. PubMed ID: 16291864
[TBL] [Abstract][Full Text] [Related]
19. FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review).
Katoh M
Int J Mol Med; 2016 Jul; 38(1):3-15. PubMed ID: 27245147
[TBL] [Abstract][Full Text] [Related]
20. The role of mutations and overexpression of the fibroblast growth factor receptor-3 in bladder cancer.
Wang QY; Zhao Y; Zhang R
Minerva Med; 2015 Dec; 106(6):333-7. PubMed ID: 26542242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
